Olaris Presents at Groundbreaking Cancer & Evolution Symposium

Dr. Elizabeth O'Day joined influential scientists in cancer biology and evolutionary biology, including Azra Raza, George Church, Adelene Perkins, Frank Laukien, and Denis Noble, at the first meeting of the Cancer and Evolution Symposium to present the Olaris BoR platform for assessing breast cancer patient response to CDK4/6 inhibitors to improve outcomes.

 

View Dr. O'Day's talk below.  

October 16, 2020

Olaris Presents at Groundbreaking Cancer & Evolution Symposium